OCLN and Alzheimer disease: In addition, MEM treatment might up‐regulate the expressions of ZO‐1, occludin and claudin‐5 via the LINC00094/miR‐224‐5p (miR‐497‐5p)/Endophilin‐1 axis, which contributed to ameliorate BBB permeability in AD microenvironment.